INFI News and Press, Infinity Pharmaceuticals Inc. From 10/23/19

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Wednesday, October 30, 2019 at 4:30 p.m. ET to review its third quarter 2019 financial results and provide an update on the company. A live webcast of the conference call can be accessed in the Investors/Media se...

CAMBRIDGE, Mass. , Sept. 4, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc.  (NASDAQ: INFI) today announced the initiation of two clinical trials for IPI-549, a first-in-class, oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells t...

CAMBRIDGE, Mass. , Sept. 3, 2019 /PRNewswire/ --   Infinity Pharmaceuticals, Inc.  (NASDAQ: INFI), a clinical-stage biotechnology company developing IPI-549, a potentially first-in-class immuno-oncology product candidate that selectively inhibits phosphoinositide-3-kinase gamma...

CAMBRIDGE, Mass. , Aug. 22, 2019 /PRNewswire/ --  Infinity Pharmaceuticals, Inc.  (NASDAQ: INFI) today announced that Samuel Agresta , M.D., will transition from his role as Chief Medical Officer to Infinity's Board of Directors and Research and Development Committee. ...

Introduction We present here some results of a study on U.S. listed companies in the healthcare sector (Nasdaq, NYSE and Amex) based on their patent activity based on PCT (Patent Cooperation Treaty) patent applications administered by the World Intellectual Property Office (WIPO). We have sh...

Infinity Pharmaceuticals, Inc. (INFI) Q2 2019 Earnings Conference Call July 30, 2019 08:00 AM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - CEO Lawrence Bloch - President Sam Agresta - Chief Medical Officer Jeff Kutok - Chief Scientif...

Infinity Pharmaceuticals (NASDAQ: INFI ): Q2 GAAP EPS of -$0.18 misses by $0.03 . More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

CAMBRIDGE, Mass. , July 30, 2019 /PRNewswire/ --  Infinity Pharmaceuticals, Inc.  (NASDAQ: INFI) today announced its second quarter 2019 financial results and provided an update on the company, including its progress with IPI-549, a first-in-class oral immuno-oncology product ...

CAMBRIDGE, Mass. , July 23, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, July 30, 2019 at 8:00 a.m. ET to review its second quarter 2019 financial results and provide an update on the company. A live webcast of t...

Oppenheimer initiates coverage on thinly traded nano cap Infinity Pharmaceuticals ( INFI +3.6% ) with an Outperform rating and $3 (74% upside) price target. More news on: Infinity Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...